T1	Condition 22 36	adenocarcinoma
T2	Condition 6 11	tumor
T3	Condition 38 77	Central nervous system (CNS) metastases
T4	Procedure 87 96	radiation
T5	Condition 101 115	CNS metastases
R2	AND Arg1:T4 Arg2:T5	
*	OR T3 T4
T6	Condition 117 143	Gastric outlet obstruction
T7	Condition 147 169	intestinal obstruction
*	OR T6 T7
T8	Condition 183 208	gastrointestinal bleeding
T9	Observation 171 182	Evidence of
R3	AND Arg1:T9 Arg2:T8	
T10	Condition 226 238	bony lesions
T11	Value 242 250	the sole
T12	Qualifier 251 268	evaluable disease
R4	Has_qualifier Arg1:T11 Arg2:T12	
R5	Has_value Arg1:T10 Arg2:T11	
T13	Observation 290 300	history of
T14	Condition 301 309	neoplasm
T15	Condition 321 335	stomach cancer
R7	AND Arg1:T13 Arg2:T14	
T16	Condition 367 391	non-melanoma skin cancer
T17	Condition 395 432	in situ carcinoma of the cervix uteri
*	OR T16 T17
T18	Procedure 359 366	treated
T19	Qualifier 348 358	curatively
R8	Has_qualifier Arg1:T18 Arg2:T19	
T20	Scope 367 432	non-melanoma skin cancer or in situ carcinoma of the cervix uteri
R9	Has_scope Arg1:T18 Arg2:T20	
T21	Condition 434 442	Pregnant
T22	Condition 446 455	lactating
T23	Person 456 461	women
*	OR T21 T22 T66
T24	Condition 472 494	childbearing potential
T25	Person 463 468	women
T26	Procedure 518 531	contraception
T27	Negation 495 508	not employing
R10	Has_negation Arg1:T26 Arg2:T27	
T28	Condition 539 554	serious illness
T29	Condition 558 576	medical conditions
*	OR T28 T29
T30	Condition 578 602	Unstable cardiac disease
T31	Procedure 611 620	treatment
T32	Condition 622 643	myocardial infarction
T33	Temporal 644 680	within 6 months prior to study entry
R11	Has_temporal Arg1:T32 Arg2:T33	
*	OR T30 T32
T34	Condition 705 715;731 740	neurologic disorders
T35	Condition 719 740	psychiatric disorders
*	OR T34 T35
T36	Condition 751 759	dementia
T37	Condition 763 771	seizures
*	OR T36 T37
T38	Scope 751 771	dementia or seizures
T39	Scope 705 740	neurologic or psychiatric disorders
R12	Subsumes Arg1:T39 Arg2:T38	
T40	Observation 682 689	History
T41	Condition 793 802	infection
T42	Qualifier 780 792	uncontrolled
R13	Has_qualifier Arg1:T41 Arg2:T42	
T43	Temporal 773 779	Active
R14	Has_temporal Arg1:T41 Arg2:T43	
T44	Condition 810 817;829 847	serious medical conditions
T45	Observation 871 908	ability of the patient to participate
R15	AND Arg1:T45 Arg2:T44	
T46	Drug 963 980	experimental drug
T47	Temporal 923 934	Concomitant
R16	Has_temporal Arg1:T46 Arg2:T47	
T48	Procedure 1017 1029	chemotherapy
T49	Procedure 1031 1047	hormonal therapy
T50	Procedure 1052 1065	immunotherapy
*	OR T50 T49 T48
T51	Temporal 1005 1016	concomitant
T52	Scope 1017 1065	chemotherapy, hormonal therapy, or immunotherapy
R17	Has_temporal Arg1:T52 Arg2:T51	
*	OR T52 T46
T53	Drug 1084 1094	medication
T54	Drug 1079 1083	drug
*	OR T54 T53
T55	Temporal 1067 1078	concomitant
T56	Scope 1079 1094	drug medication
R18	Has_temporal Arg1:T56 Arg2:T55	
T57	Drug 1153 1161	Warfarin
T58	Drug 1163 1176	phenprocoumon
T59	Measurement 1187 1204	bleeding tendency
T60	Measurement 1218 1250	blood concentration of phenytoin
T61	Value 1209 1217	Increase
R19	Has_value Arg1:T60 Arg2:T61	
T62	Drug 1256 1266	sorivudine
T63	Drug 1335 1346	allopurinol
T64	Value 1178 1186	increase
R20	Has_value Arg1:T59 Arg2:T64	
T65	Drug 1314 1330	fluoropyrimidine
T66	Scope 472 531	childbearing potential not employing adequate contraception
*	OR T57 T58
*	OR T65 T63 T62
T67	Non-representable 1178 1204	increase bleeding tendency
T68	Non-representable 1209 1250	Increase blood concentration of phenytoin
T69	Non-representable 1096 1148	The following drugs cause drug interaction with S-1.
T70	Negation 310 320	other than
R6	Has_negation Arg1:T15 Arg2:T70	
R21	AND Arg1:T14 Arg2:T15	
T71	Negation 337 347	except for
R22	AND Arg1:T14 Arg2:T18	
T72	Negation 0 5	Other
R1	Has_negation Arg1:T1 Arg2:T72	
R23	AND Arg1:T2 Arg2:T1	
R24	Has_negation Arg1:T18 Arg2:T71	
